Concepedia

Lukas de Haas

LD

Statistics

Publications

1

Citations

23

H-Index

1

Active since

2022

Affiliations

Radboud Institute for Molecular Life Sciences(Current)

Lukas de Haas is an author at Radboud Institute for Molecular Life Sciences specializing in tumor antigen cross-presentation, cancer vaccines, and dendritic cell targeting.

ORCID

Publications per year

2022–2022

1

Publications

1

Efficient targeting of NY-ESO-1 tumor antigen to human cDC1s by lymphotactin results in cross-presentation and antigen-specific T cell expansion

Camille M. Le Gall, Anna Cammarata, Lukas de Haas et al. · Journal for ImmunoTherapy of Cancer · 2022 · 23 citations · Full text

Life Sciences, Immunology, Oncology +17

1–1 of 1